Insights & News

Recent safety updates issued by the French National Agency for the Safety of Medicines and Health Products (ANSM) have once again drawn international attention to the potential cardiovascular risks associated with sclerotherapy for varicose veins, particularly foam sclerotherapy. Despite longstanding enhanced pharmacovigilance measures, serious adverse events including deep vein thrombosis, pulmonary embolism, and cardiac arrhythmias continue to be reported. This regulatory update highlights the growing global emphasis on patient selection, hemodynamic assessment, procedural standardization, and long-term safety outcomes in modern venous medicine.

This article highlights a critical paradigm shift in venous ulcer management, challenging the “gold standard” of Great Saphenous Vein (GSV) ablation. Recent findings by Bishara et al. (2024) demonstrate that in patients with Post-Thrombotic Syndrome (PTS) and deep venous obstruction, the GSV acts as a vital collateral bypass rather than a source of reflux. The study reveals that preserving the GSV in these specific cases leads to significantly higher healing probabilities and lower recurrence rates, whereas premature ablation can elevate regional venous pressure and stall recovery. A rigorous assessment of deep vein patency is now considered a mandatory prerequisite before any superficial intervention.

The Asian Venous Academy (AVA) has appointed Yibing Gang, a distinguished expert in global health policy and institutional development, as Director of International Programs. Formerly the Head of International Cooperation at the China Hospital Association, Gang brings a wealth of experience in forging high-level healthcare partnerships across ASEAN, Europe, and the SCO. In this strategic role, she will spearhead AVA’s international academic initiatives and expand cross-border knowledge exchange, further solidifying the Academy’s commitment to advancing global standards in venous disease management.

A recent systematic review and meta-analysis published in the Annals of Vascular Surgery (February 2026) evaluates the efficacy of the hemodynamic-based CHIVA technique compared to traditional destructive treatments like stripping and thermal ablation (EVLA/RFA). Analyzing data from 11 studies and over 13,000 patients, the research demonstrates that CHIVA significantly reduces the risk of saphenous nerve injury and postoperative ecchymosis while maintaining equivalent results in recurrence rates and safety profiles. This study reinforces CHIVA’s position as a superior, minimally invasive alternative for venous disease management.

Can medical science save a dying local industry? The “NARA Socks Project” demonstrates how Japanese clinicians are reviving Nara’s traditional hosiery sector by transforming craftsmanship into preventive compression therapy. Proving that “non-medical” gear can still deliver significant hemodynamic benefits—like increased blood flow and reduced venous stasis—this initiative offers a high-value blueprint for merging public health with industrial survival. It’s a compelling look at how clinical evidence can turn a commodity into a life-saving essential.

Is non-invasive energy the future of venous care? New evidence from JVS-VL evaluates the integration of HIFU and the CHIVA strategy. Discover how the Asian Venous Academy is framing the dialogue between cutting-edge tech and hemodynamic logic ahead of the 2026 Asian Venous Summit in Hong Kong.

As autonomous AI robots like the SRT-H begin to perform surgeries without human intervention, the surgical profession faces a pivotal transformation. In this exclusive dialogue, Dr. Qiang Zhang and Daniel Ho (Asian Venous Academy) discuss why AI is not the end of the surgeon, but a catalyst for a “higher-dimensional” career definition. From the hemodynamic philosophy of CHIVA to the future of systemic medical logic, discover why the most critical skill for the modern surgeon may soon be deciding when not to operate.

A global meta-analysis reveals that 25% of healthcare workers suffer from varicose veins, with prevalence reaching nearly 30% in developing regions. This occupational health challenge highlights the urgent need for institutional preventive measures and better workplace ergonomics in the medical field.